MK-8457

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MK-8457, covering 2017-02-23 to 2017-05-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Effect of MK-8457 on Blood Pressure in Hypertensive Participants (MK-8457-004-AM1) [Phase 1]